Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

SRRK

Scholar Rock Holding Corp

Dec 11 • 04:00PM ET

42.18

Dollar change -2.34
Percentage change -5.26	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX REGN NBIX SRPT BMRN RARE FOLD IONS BLUE CARA

| Held by: IWM VTI XBI VXF IWO IBB SCHA VTWO IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.47	Insider Own	26.26%	Shs Outstand	80.08M	Perf Week	6.06%
Market Cap	3.95B	Forward P/E	-	EPS next Y	-2.23	Insider Trans	-7.53%	Shs Float	69.03M	Perf Month	49.84%
Income	-225.97M	PEG	-	EPS next Q	-0.60	Inst Own	71.64%	Short Float	21.36%	Perf Quarter	410.65%
Sales	0.00M	P/S	-	EPS this Y	-22.05%	Inst Trans	-0.12%	Short Ratio	7.10	Perf Half Y	349.20%
Book/sh	0.99	P/B	42.65	EPS next Y	8.29%	ROA	-105.14%	Short Interest	14.75M	Perf Year	133.43%
Cash/sh	1.49	P/C	28.40	EPS next 5Y	-	ROE	-183.07%	52W Range	6.76 - 46.19	Perf YTD	124.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.79%	ROI	-161.68%	52W High	-8.67%	Beta	0.54
Dividend TTM	-	Quick Ratio	3.88	Sales past 5Y	-5.25%	Gross Margin	-	52W Low	523.96%	ATR (14)	2.87
Dividend Ex-Date	-	Current Ratio	3.88	EPS Y/Y TTM	-9.56%	Oper. Margin	-	RSI (14)	67.12	Volatility	8.07% 7.59%
Employees	150	Debt/Eq	0.84	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	44.12
Option/Short	Yes / Yes	LT Debt/Eq	0.76	EPS Q/Q	-26.43%	Payout	-	Rel Volume	0.51	Prev Close	44.52
Sales Surprise	-	EPS Surprise	-13.77%	Sales Q/Q	-	Earnings	Nov 12 BMO	Avg Volume	2.08M	Price	42.18
SMA20	19.21%	SMA50	39.45%	SMA200	163.48%	Trades		Volume	1,058,258	Change	-5.26%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-26-24	Reiterated	H.C. Wainwright	Buy	$40 → $50
Oct-07-24	Reiterated	H.C. Wainwright	Buy	$30 → $35
Mar-28-24	Initiated	Raymond James	Strong Buy	$30
Oct-25-23	Upgrade	Jefferies	Hold → Buy	$20
Apr-03-23	Resumed	Piper Sandler	Overweight	$26
Sep-19-22	Resumed	H.C. Wainwright	Buy	$30
Jul-12-22	Initiated	Truist	Buy	$20
Mar-23-22	Initiated	H.C. Wainwright	Buy	$24
Dec-22-21	Downgrade	Jefferies	Buy → Hold	$52 → $28
Nov-19-21	Initiated	Piper Sandler	Overweight	$56
Apr-26-21	Resumed	Credit Suisse	Outperform	$65
Jan-11-21	Initiated	Credit Suisse	Outperform	$65
Jan-06-21	Initiated	JP Morgan	Overweight	$59
Mar-12-20	Initiated	Robert W. Baird	Outperform	$35

Show Previous Ratings

Dec-04-24 12:36PM	Why Is Scholar Rock Holding Corporation (SRRK) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? (Insider Monkey)
Nov-25-24 11:51AM	Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study (Benzinga) +26.07%
06:13AM	Biohaven muscle drug misses goal of SMA study, but advances in obesity (BioPharma Dive)
Nov-15-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-13-24 02:08AM	Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
07:00AM	Loading…
Nov-12-24 07:00AM	Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress (Business Wire) -5.29%
Nov-11-24 07:07AM	Scholar Rock Holding Corp (SRRK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-04-24 08:00AM	Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin (Business Wire)
Nov-01-24 08:00AM	Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024 (Business Wire)
Oct-31-24 04:00PM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire) -5.14%
08:00AM	Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting (Business Wire)
Oct-22-24 08:00AM	Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering (Business Wire)
Oct-21-24 09:55AM	Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross? (Zacks)
Oct-18-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-11-24 06:30PM	PBF Energy, Gold Reserve, and More Stocks See Action From Activist Investors (Barrons.com) +7.58%
05:34PM	Loading…
Oct-09-24 05:34PM	Scholar Rock Holding Corp (SRRK) Q2 2024 Earnings Call Highlights: Advancing Key Milestones in ... (GuruFocus.com) -5.83% -5.87%
05:38AM	Here's Why Everybody's Talking About Scholar Rock Right Now (Motley Fool)
Oct-08-24 11:08PM	Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants (Business Wire) -13.97%
08:29AM	Scholar Rocks SMA Treatment Trials Show Promising Results (TipRanks)
06:43AM	Scholar Rock stocks skyrocket after SMA drug scores at Phase III (Clinical Trials Arena)
Oct-07-24 04:13PM	Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy (Investor's Business Daily) +361.99%
04:09PM	Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (Business Wire)
03:23PM	Scholar Rock Shares Quadruple On Positive Drug-Study Results (The Wall Street Journal)
11:05AM	Scholar Rock stock surges on positive spinal muscular atrophy treatment data (Investing.com)
11:05AM	Scholar Rock Stock Quadruples on Positive Trial Data (Barrons.com)
09:41AM	Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy (Investor's Business Daily)
07:00AM	Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA) (Business Wire)
Sep-27-24 06:13AM	Scholar Rock Holding Corporation (NASDAQ:SRRK) Ranks High On The List Of Worst Falling Stocks To Buy Now (Insider Monkey)
Sep-13-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.48%
Sep-10-24 08:00AM	Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity (Business Wire) +5.89%
12:02AM	Loading…
Sep-05-24 12:02AM	Scholar Rock Holding Corporation (SRRK): This Small-Cap Healthcare Stock Is A Good Buy Right Now (Insider Monkey)
Sep-04-24 08:00AM	Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer (Business Wire)
Sep-02-24 05:22PM	10 Best Small-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-29-24 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Aug-16-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-15-24 04:32AM	Scholar Rocks apitegromab shows promise for non-ambulatory SMA (Clinical Trials Arena)
Aug-09-24 05:05AM	Q2 2024 Scholar Rock Holding Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-08-24 07:00AM	Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress (Business Wire)
Jul-23-24 08:00AM	Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 (Business Wire)
Jul-12-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-08-24 06:42PM	Scholar Rock Holding Corporation (SRRK): The Most Shorted Stock Loved by Analysts? (Insider Monkey)
12:30PM	10 Most Shorted Stocks That Are Loved by Analysts (Insider Monkey)
Jun-24-24 07:00AM	Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal (Business Wire)
Jun-18-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-03-24 04:00PM	Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting (Business Wire)
May-28-24 08:00AM	Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire)
May-22-24 07:00AM	Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity (Business Wire)
May-20-24 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
May-17-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -12.78%
May-14-24 08:00AM	Scholar Rock to Host Investor Day on May 22, 2024 (Business Wire)
May-07-24 01:53PM	SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q1 2024 (InvestorPlace)
10:19AM	Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss (MT Newswires)
08:52AM	Scholar Rock Holding Corp (SRRK) Reports Q1 2024 Financial Results: A Detailed Analysis (GuruFocus.com)
07:00AM	Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress (Business Wire)
Apr-24-24 06:33AM	3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains (InvestorPlace)
Apr-12-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.08%
Mar-20-24 05:31AM	Scholar Rock Holding Corp Reports Full Year 2023 Financial Results (GuruFocus.com) +8.58%
Mar-19-24 10:52PM	SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023 (InvestorPlace) +14.77%
07:00AM	Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress (Business Wire)
Mar-15-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -8.65%
08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Feb-28-24 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Feb-16-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.42%
Feb-15-24 08:00AM	Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer (Business Wire)
Feb-06-24 08:00AM	Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management (Business Wire)
Jan-25-24 08:00AM	Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia (Business Wire)
Jan-23-24 08:00AM	Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity (Business Wire)
Jan-22-24 07:00AM	Obesity Drugs Lead to Muscle LossPharma Companies Want to Fix That (The Wall Street Journal)
Jan-18-24 05:01PM	Insider Edward Myles Sells 6,634 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com) -5.10%
Jan-12-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-04-24 08:00AM	Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 (Business Wire)
Jan-02-24 01:57PM	3 Biotech Stocks at the Forefront of the Quest for Eternal Youth (InvestorPlace) -6.91%
Dec-30-23 07:01PM	Insider Edward Myles Sells 12,459 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
Dec-19-23 08:00AM	Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +5.29%
Dec-15-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.43%
Dec-10-23 09:05AM	Insider Sell: COO & CFO Edward Myles Sells 24,914 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
Nov-17-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-12-23 12:32PM	Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 08:14AM	Scholar Rock Holding Corp (SRRK) Reports Q3 2023 Financial Results (GuruFocus.com)
07:15AM	Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress (Business Wire)
Nov-06-23 09:55AM	Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move This High? (Zacks)
Nov-03-23 11:52PM	Insider Sell: Edward Myles Sells 35,007 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
04:00PM	Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability (Business Wire)
Nov-02-23 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-23 08:50AM	Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK) (Zacks)
Oct-24-23 12:00PM	All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy (Zacks)
Oct-23-23 08:00AM	Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 (Business Wire)
Oct-19-23 09:55AM	Wall Street Analysts Think Scholar Rock Holding Corporation (SRRK) Could Surge 203.99%: Read This Before Placing a Bet (Zacks)
08:00AM	Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting (Business Wire)
Oct-18-23 08:30AM	Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More (Zacks) -13.56%
Oct-16-23 04:15PM	Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares (Business Wire) +5.36% +5.33%
Oct-13-23 12:45PM	Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering (Zacks)
Oct-12-23 04:17PM	Why Scholar Rock Holding Stock Soared Today (Motley Fool) +17.66%
Oct-11-23 08:57PM	Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock (Business Wire)
05:05PM	Scholar Rock Announces Proposed Public Offering of Common Stock (Business Wire)
04:44PM	Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders (Business Wire)
Sep-19-23 08:00AM	Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial (Business Wire) +10.74%
Sep-15-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-07-23 09:55AM	Wall Street Analysts Believe Scholar Rock Holding Corporation (SRRK) Could Rally 264.53%: Here's is How to Trade (Zacks)
Aug-18-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +7.93%

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Invus Public Equities, L.P.	10% Owner	Nov 25 '24	Sale	38.49	409,433	15,757,639	10,850,005	Nov 27 04:31 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 25 '24	Option Exercise	8.59	6,375	54,761	79,230	Nov 26 05:00 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 22 '24	Option Exercise	8.59	2,145	18,426	75,000	Nov 26 05:00 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 25 '24	Sale	39.44	6,375	251,399	72,855	Nov 26 05:00 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 22 '24	Sale	30.01	2,145	64,372	72,855	Nov 26 05:00 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 11 '24	Option Exercise	8.59	2,105	18,082	74,960	Nov 13 04:40 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Nov 11 '24	Sale	30.00	2,105	63,158	72,855	Nov 13 04:40 PM
Myles Edward H	COO & CFO	Oct 08 '24	Option Exercise	10.00	37,187	371,870	198,275	Oct 10 06:00 PM
Myles Edward H	COO & CFO	Oct 08 '24	Sale	34.90	37,187	1,297,659	161,088	Oct 10 06:00 PM
Myles Edward H	COO & CFO	Oct 07 '24	Sale	26.56	206,240	5,477,546	161,088	Oct 07 09:52 PM
Sacco Tracey	CHIEF COMMERCIAL OFFICER	Oct 07 '24	Option Exercise	10.00	30,000	300,000	79,285	Oct 07 09:03 PM
Sacco Tracey	CHIEF COMMERCIAL OFFICER	Oct 07 '24	Sale	25.62	30,000	768,677	49,285	Oct 07 09:03 PM
AKKARAJU SRINIVAS	Director	Oct 07 '24	Sale	29.25	1,175,713	34,385,672	5,612,896	Oct 07 08:55 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Oct 07 '24	Option Exercise	8.59	109,375	939,531	182,230	Oct 07 08:51 PM
Marantz Jing L.	CHIEF MEDICAL OFFICER	Oct 07 '24	Sale	27.21	109,375	2,976,468	72,855	Oct 07 08:51 PM
AKKARAJU SRINIVAS	Director	Oct 07 '24	Proposed Sale	29.25	1,175,713	34,385,725		Oct 07 08:43 PM
Tracey Sacco	Officer	Oct 07 '24	Proposed Sale	25.62	30,000	768,693		Oct 07 04:20 PM
Jing Marantz	Officer	Oct 07 '24	Proposed Sale	32.50	120,000	3,900,000		Oct 07 04:18 PM
Edward Myles	Officer	Oct 07 '24	Proposed Sale	32.50	243,427	7,911,378		Oct 07 04:16 PM
Qatanani Mo	CHIEF SCIENTIFIC OFFICER	Sep 16 '24	Sale	8.58	1,936	16,611	142,768	Sep 19 08:15 AM
Parlavecchio Caryn	CHRO	Aug 16 '24	Sale	9.33	1,451	13,538	151,988	Aug 19 05:00 PM
Qatanani Mo	CHIEF SCIENTIFIC OFFICER	Jun 17 '24	Sale	8.98	2,315	20,800	144,704	Jun 18 05:56 PM
Parlavecchio Caryn	CHRO	Jun 17 '24	Sale	8.98	4,305	38,680	153,439	Jun 18 05:55 PM
Myles Edward H	COO & CFO	Jun 17 '24	Sale	8.98	9,458	84,978	201,518	Jun 18 05:54 PM
Ho Junlin	GENERAL COUNSEL	Jun 17 '24	Sale	8.98	4,695	42,183	204,076	Jun 18 05:53 PM
Myles Edward H	COO & CFO	Feb 16 '24	Sale	15.74	4,744	74,686	210,976	Feb 21 06:13 PM
Qatanani Mo	CHIEF SCIENTIFIC OFFICER	Feb 16 '24	Sale	15.74	2,512	39,547	147,019	Feb 20 04:58 PM
Parlavecchio Caryn	CHRO	Feb 16 '24	Sale	15.74	3,751	59,053	157,744	Feb 20 04:52 PM
Ho Junlin	GENERAL COUNSEL	Feb 16 '24	Sale	15.74	3,489	54,928	208,771	Feb 20 04:48 PM
Backstrom Jay T.	CHIEF EXECUTIVE OFFICER	Feb 16 '24	Sale	15.74	11,614	182,842	352,671	Feb 20 04:46 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Jan 16 '24	Sale	15.93	2,002	31,889	78,816	Jan 18 04:11 PM
Parlavecchio Caryn	CHRO	Jan 16 '24	Sale	15.93	2,849	45,381	114,350	Jan 18 04:08 PM
Myles Edward H	COO & CFO	Jan 16 '24	Sale	15.93	6,634	105,670	162,150	Jan 18 04:07 PM
Ho Junlin	GENERAL COUNSEL	Jan 16 '24	Sale	15.93	4,186	66,677	154,405	Jan 18 04:05 PM
Myles Edward H	COO & CFO	Dec 29 '23	Option Exercise	4.86	12,459	60,551	181,243	Dec 29 07:13 PM
Myles Edward H	COO & CFO	Dec 29 '23	Sale	18.83	12,459	234,633	168,784	Dec 29 07:13 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Dec 14 '23	Option Exercise	10.00	8,437	84,370	105,480	Dec 15 04:13 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Dec 14 '23	Sale	18.18	24,662	448,444	80,818	Dec 15 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SRRK

Scholar Rock Holding Corp

Upgrade your FINVIZ experience